<- Go Home
FibroBiologics, Inc.
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.
Market Cap
$17.5M
Volume
325.9K
Cash and Equivalents
$4.9M
EBITDA
-$17.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$2.98
52 Week Low
$0.28
Dividend
N/A
Price / Book Value
131.32
Price / Earnings
-0.70
Price / Tangible Book Value
131.32
Enterprise Value
$19.7M
Enterprise Value / EBITDA
-1.18
Operating Income
-$17.8M
Return on Equity
1292.87%
Return on Assets
-115.62
Cash and Short Term Investments
$4.9M
Debt
$7.1M
Equity
$125.0K
Revenue
N/A
Unlevered FCF
-$12.9M
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium